Green Cross joint anti-cancer drug research with MD Anderson Cancer Center.

Published: 2006-02-09 06:57:00

Updated: 2006-02-09 06:57:00

Mokam Bio Engineering Research Institute, an affiliated institute of Green Cross, agreed a joint research and development with MD Anderson Cancer Center in the United States for Greenstatin, a novel anti-angiogenesis anti-cancer drug.

Anderson Cancer Center was established in 1941, with reputa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK